Skip to main content
Premium Trial:

Request an Annual Quote

Steve Martin, Peter Juhasz, Hans Baum, Peter Wilver, Theo Melas-Kyriazi, Leroy Hood, Martin Vingron, Gene Myers


Steve Martin, director of Applied Biosystems’ Proteomics Research Center in Framington, Mass., has left the company, ABI spokeswoman Amy Speak confirmed last week. Martin left last month and will be replaced by Peter Juhasz, Speak said. She did not say why Martin left, or where he is headed.

Hans Baum has become vice president of European operations of Bruker Daltonics. Baum has held various positions at Bruker Daltonik in Germany since 1987. Prior to joining the company, Baum served in the German Armed Forces as a nuclear, biological, and chemical defense officer.

Peter Wilver will become chief financial officer at Thermo Electron as of Oct. 1. He is currently vice president of financial operations. Wilver will replace current CFO Theo Melas-Kyriazi. Prior to joining Thermo, Wilver held various finance positions at Honeywell International. Prior to that, he worked at Grimes Aerospace and General Electric.

Leroy Hood will receive the 6th annual Biotechnology Heritage Award, the Chemical Heritage Foundation and the Biotechnology Industry Organization said in April. The presentation will be made next Monday at BIO 2004 in San Francisco. CHF and BIO are honoring Hood for his role in developing automated sequencing technology. Hood is the president and co-founder of the Institute for Systems Biology in Seattle. He holds a PhD in biochemistry from California Technical Institue and an MD from Johns Hopkins University.

Martin Vingron and Gene Myers have received this year’s Max Planck Research Prize. The award ceremony will take place in Stuttgart, Germany, on June 24.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.